301 related articles for article (PubMed ID: 26367092)
1. Primary CNS lymphoma.
Touitou V; LeHoang P; Bodaghi B
Curr Opin Ophthalmol; 2015 Nov; 26(6):526-33. PubMed ID: 26367092
[TBL] [Abstract][Full Text] [Related]
2. Association of interleukin 10 in the vitreous and cerebrospinal fluid and primary central nervous system lymphoma.
Whitcup SM; Stark-Vancs V; Wittes RE; Solomon D; Podgor MJ; Nussenblatt RB; Chan CC
Arch Ophthalmol; 1997 Sep; 115(9):1157-60. PubMed ID: 9298057
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological analysis and specific discriminating markers of interleukin detection in cerebrospinal fluid with primary central nervous system lymphoma: results from a retrospective study.
Li J; Tang X; Luo X; Liu L; Li D; Yang L
Ann Hematol; 2023 Aug; 102(8):2153-2163. PubMed ID: 37289220
[TBL] [Abstract][Full Text] [Related]
4. A diagnostic challenge of primary Central nervous system lymphoma: from the eyes to the brain.
Su M; Huang D; Sun L; Dong Z; Wu L; Yu S
Int J Neurosci; 2021 Nov; 131(11):1139-1145. PubMed ID: 32449877
[TBL] [Abstract][Full Text] [Related]
5. Treatment options for central nervous system lymphomas in immunocompetent patients.
Jahnke K; Thiel E
Expert Rev Neurother; 2009 Oct; 9(10):1497-509. PubMed ID: 19831839
[TBL] [Abstract][Full Text] [Related]
6. The CSF IL-10 concentration is an effective diagnostic marker in immunocompetent primary CNS lymphoma and a potential prognostic biomarker in treatment-responsive patients.
Nguyen-Them L; Costopoulos M; Tanguy ML; Houillier C; Choquet S; Benanni H; Elias-Shamieh R; Armand M; Faivre G; Glaisner S; Malak S; Vargaftig J; Hoang-Xuan K; Ahle G; Touitou V; Cassoux N; Davi F; Merle-Béral H; Le Garff-Tavernier M; Soussain C;
Eur J Cancer; 2016 Jul; 61():69-76. PubMed ID: 27156226
[TBL] [Abstract][Full Text] [Related]
7. Elevated vitreous interleukin-10 level is not diagnostic of intraocular-central nervous system lymphoma.
Akpek EK; Maca SM; Christen WG; Foster CS
Ophthalmology; 1999 Dec; 106(12):2291-5. PubMed ID: 10599659
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal Fluid IL-10 and IL-10/IL-6 as Accurate Diagnostic Biomarkers for Primary Central Nervous System Large B-cell Lymphoma.
Song Y; Zhang W; Zhang L; Wu W; Zhang Y; Han X; Yang C; Zhang L; Zhou D
Sci Rep; 2016 Dec; 6():38671. PubMed ID: 27924864
[TBL] [Abstract][Full Text] [Related]
9. CSF interleukin 6 is a useful marker to distinguish pseudotumoral CNS inflammatory diseases from primary CNS lymphoma.
Ungureanu A; Le Garff-Tavernier M; Costopoulos M; Parratte T; Brinet A; Durand H; Gaultier C; Hurstel R; Alamome I; Sellal F; Ahle G
J Neurol; 2021 Aug; 268(8):2890-2894. PubMed ID: 33609156
[TBL] [Abstract][Full Text] [Related]
10. Primary central nervous system lymphoma: an update.
Soussain C; Hoang-Xuan K
Curr Opin Oncol; 2009 Nov; 21(6):550-8. PubMed ID: 19684518
[TBL] [Abstract][Full Text] [Related]
11. [Diagnostics and treatment of primary vitreoretinal lymphoma].
Stübiger N; Kakkassery V; Gundlach E; Winterhalter S; Pleyer U
Ophthalmologe; 2015 Mar; 112(3):223-30. PubMed ID: 25698590
[TBL] [Abstract][Full Text] [Related]
12. Primary central nervous system lymphoma: time for diagnostic biomarkers and biotherapies?
Royer-Perron L; Hoang-Xuan K; Alentorn A
Curr Opin Neurol; 2017 Dec; 30(6):669-676. PubMed ID: 28922238
[TBL] [Abstract][Full Text] [Related]
13. Molecular analysis of primary central nervous system and primary intraocular lymphomas.
Tuaillon N; Chan CC
Curr Mol Med; 2001 May; 1(2):259-72. PubMed ID: 11899075
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and treatment of primary CNS lymphoma.
Korfel A; Schlegel U
Nat Rev Neurol; 2013 Jun; 9(6):317-27. PubMed ID: 23670107
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis and management of primary CNS lymphoma.
Roth P; Korfel A; Martus P; Weller M
Expert Rev Anticancer Ther; 2012 May; 12(5):623-33. PubMed ID: 22594897
[TBL] [Abstract][Full Text] [Related]
16. Primary central nervous system lymphoma.
Abrey LE
Curr Opin Neurol; 2009 Dec; 22(6):675-80. PubMed ID: 19741527
[TBL] [Abstract][Full Text] [Related]
17. Primary intraocular lymphoma.
Sagoo MS; Mehta H; Swampillai AJ; Cohen VM; Amin SZ; Plowman PN; Lightman S
Surv Ophthalmol; 2014; 59(5):503-16. PubMed ID: 24560125
[TBL] [Abstract][Full Text] [Related]
18. Primary central nervous system lymphoma - ocular variant: an interdisciplinary review on management.
Raval V; Binkley E; Aronow ME; Valenzuela J; Peereboom DM; Singh AD
Surv Ophthalmol; 2021; 66(6):1009-1020. PubMed ID: 33762182
[TBL] [Abstract][Full Text] [Related]
19. Mouse models of primary central nervous system lymphomas: tools for basing funding and therapeutic strategies.
Ben Abdelwahed Bagga R; Donnou S; Cosette J; Sautès-Fridman C; Aouni M; Fisson S
J Neurooncol; 2015 Jan; 121(1):9-18. PubMed ID: 25300908
[TBL] [Abstract][Full Text] [Related]
20. Primary CNS lymphoma with intraocular involvement: International PCNSL Collaborative Group Report.
Grimm SA; McCannel CA; Omuro AM; Ferreri AJ; Blay JY; Neuwelt EA; Siegal T; Batchelor T; Jahnke K; Shenkier TN; Hall AJ; Graus F; Herrlinger U; Schiff D; Raizer J; Rubenstein J; Laperriere N; Thiel E; Doolittle N; Iwamoto FM; Abrey LE
Neurology; 2008 Oct; 71(17):1355-60. PubMed ID: 18936428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]